Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Kala Bio Inc.
Headquarters: Waltham, MA, United States of America
Website: http://www.kalarx.com
Year Founded: 2009
Status: Public
Industry Sector: HealthTechnology
CEO: Todd Bazemore
Number Of Employees: 43
Enterprise Value: $2,452,056
PE Ratio: -0.54
Exchange/Ticker 1: NASDAQ:KALA
Exchange/Ticker 2: N/A
Latest Market Cap: $41,115,500
BioCentury | Feb 13, 2025
Management Tracks
Lee joins Lycia as CMO
Plus: Firth joins Panacea, Lakewood appoints Manion chair and updates from Ai Proteins, Cognito and Kala
BioCentury | Jun 1, 2024
Management Tracks
Verve promotes Lister to CSO
Plus: Quantum-Si appoints Kummeth independent chair and updates from Alkeus and SAB
Items per page:
1 - 2 of 2